Beta-Blockers May Enhance Immunotherapy for Melanoma

Share this post

A chart review study suggests that pan-beta-blockers, such as propranolol, may improve outcomes in metastatic melanoma.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply